Dose response of N-butyl-N-(4-hydroxybutyl)nitrosamine on urinary bladder carcinogenesis in mutant ODS rats lacking l-ascorbic acid synthesizing ability

Add time:09/02/2019    Source:sciencedirect.com

With a daily intake of 250 ppm total ascorbic acid, ODS and F344 male rats were given 0.0125%, 0.025% or 0.05% N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) in the drinking water for 12 weeks, and additional groups received 0.05% BBN for 2, 4 or 8 weeks. The experiment was terminated after a total of 36 weeks. A greater response to urinary bladder carcinogenesis was observed in both strains with increasing dose of BBN or longer treatment period. However, the magnitude of urinary bladder carcinogenesis in ODS rats given the higher BBN concentrations and/or long periods of BBN treatment was less than in comparably treated F344 rats, but not with lower concentrations of BBN and/or shorter periods of BBN treatment.

We also recommend Trading Suppliers and Manufacturers of N-(4-Hydroxybutyl)-N-nitrosourea (cas 108278-69-9). Pls Click Website Link as below: cas 108278-69-9 suppliers

Prev:Antiherpetic activity and mechanism of action of 9-(4-hydroxybutyl)guanine
Next:Bis (2-Methoxyethyl) Ether)